Pathway Medical

Pathway Medical Technologies, Inc. was founded to develop, manufacture and market medical devices for the treatment of arterial disease. The company's initial focus is treating peripheral arterial disease (PAD) more quickly, safely and effectively than existing technologies. An estimated 12 million people are afflicted by PAD in the United States, and this number is projected to grow to over 20 million people during the next 10 years. The JETSTREAM Navitus™ System includes a revascularization catheter which allows for a minimally invasive procedure designed to restore circulation in the peripheral arteries by removing hard and soft plaque, calcium, thrombus, and fibrotic lesions. MEDRAD, Inc., a business of Bayer HealthCare (BHC) and part of the Radiology and Interventional business unit, acquired Pathway Medical Technologies, Inc. in the third quarter of 2011. Pathway Medical Technologies, Inc. was merged into MEDRAD, Inc. on March 31, 2012.